arrow
K

Ka-Won Kang

Korea University College of Medicine
H指数:15
被引数:1,175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study

免疫性血小板减少症二线治疗中脾切除或促血小板生成素受体激动剂的治疗模式与安全性结局:基于韩国医保数据的回顾性研究

2026-09-290
OAAI
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

套细胞淋巴瘤巩固治疗的治疗演变及对生存的影响:来自亚太地区真实世界登记研究的见解

2026-05-290
OAAI
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

阿卡拉布替尼联合来那度胺和利妥昔单抗治疗复发/难治性侵袭性b细胞非霍奇金淋巴瘤的单臂II期临床试验

2024-03-303
OAAI
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
2023-08-222
OAAI
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
2023-06-262
OAAI